29.03.2022 - Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced it has partnered with the Alzheimer’s Drug Discovery Foundation (ADDF) to accelerate . Seite 1
Funding will power a series of prospective clinical trials to validate Quanterix' multi-analyte test in collaboration with Amsterdam University Medical Centers (Amsterdam UMC) Quanterix Corporation
Leading academic lab harnesses Simoa digital biomarker analysis technology providing up to 1000x greater sensitivity than traditional immunoassays Powering Precision Health 2022 Alzheimer's podcast
08.02.2022 - Quanterix Corporation (NASDAQ: QTRX), a company digitizing biomarker analysis with the goal of advancing the science of precision health, today announced its Simoa technology is powering groundbreaking neurodegenerative disease research at the . Seite 1
UK Dementia Research Institute Biomarker Factory Powers Alzheimer s Disease Breakthroughs with Quanterix Simoa® Technology morningstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from morningstar.com Daily Mail and Mail on Sunday newspapers.